Financing

• Transave completed a Series A financing for $4 million in August 2000.  This round was led by Techno Venture Management a world leading venture capital investment group in the biotechnology field.
  
  
• The company completed a $14 million Series B financing in December 2002 lead by Forbion Capital Partners and Easton Hunt Capital Partners. TVM-Capital also participated.
  
  
• The company completed a $40 million Series C Private Financing in February 2006, lead by Prospect Venture Partners and Fidelity Biosciences. Additional investments were made by TVM Capital, Forbion Capital Partners and Easton Capital.
  
  
• Transave recently completed a $35 million Series D financing, lead by Quaker BioVentures and Bessemer Venture Partners. Additional Investments were made by TVM Capital, Prospect Venture Partners, Fidelity Biosciences, Forbion Capital Partners and Easton Capital.
  
  

Transave has recently closed a $35 million Series D private equity financing.